APO Research
Talk to an analyst

APO RESEARCH · REPORT

Home Insulin Delivery (Dosing) Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Home Insulin Delivery (Dosing) Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026196 pages

Choose your research edition.

Industry ResearchHome Insulin Delivery (Dosing) Devices Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Home Insulin Delivery (Dosing) Devices Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Home Insulin Delivery (Dosing) Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Home Insulin Delivery (Dosing) Devices Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Home Insulin Delivery (Dosing) Devices Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Home Insulin Delivery (Dosing) Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Home Insulin Delivery (Dosing) Devices include Medtronic, Ypsomed Holding, Wockhardt, West Pharma, Valeritas, Tandem Diabetes Care, SOOIL, Sanofi and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Home Insulin Delivery (Dosing) Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Home Insulin Delivery (Dosing) Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Home Insulin Delivery (Dosing) Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Insulin Delivery (Dosing) Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Home Insulin Delivery (Dosing) Devices Segment by Company

Medtronic

Ypsomed Holding

Wockhardt

West Pharma

Valeritas

Tandem Diabetes Care

SOOIL

Sanofi

Roche Holding AG

Owen Mumford

Novo Nordisk

MannKind

Julphar

Insulet Corporation

Eli Lilly and Company

Debiotech

Dance Biopharm

Copernicus

Biocon

Beta Bionics

BD

B. Braun

Home Insulin Delivery (Dosing) Devices Segment by Type

Insulin Pumps

Insulin Pens

Insulin Syringes

Others

Home Insulin Delivery (Dosing) Devices Segment by Application

Online Pharmacy

Retail Pharmacy

Hospitals Pharmacy

Home Insulin Delivery (Dosing) Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Insulin Delivery (Dosing) Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Insulin Delivery (Dosing) Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Insulin Delivery (Dosing) Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Home Insulin Delivery (Dosing) Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Home Insulin Delivery (Dosing) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Home Insulin Delivery (Dosing) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Home Insulin Delivery (Dosing) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Home Insulin Delivery (Dosing) Devices Industry Trends Table 2. Home Insulin Delivery (Dosing) Devices Industry Drivers Table 3. Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges Table 4. Home Insulin Delivery (Dosing) Devices Industry Restraints Table 5. Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Home Insulin Delivery (Dosing) Devices Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers Table 9. Global Home Insulin Delivery (Dosing) Devices Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Home Insulin Delivery (Dosing) Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Home Insulin Delivery (Dosing) Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Home Insulin Delivery (Dosing) Devices Manufacturers, Product Type & Application Table 13. Global Home Insulin Delivery (Dosing) Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Home Insulin Delivery (Dosing) Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Insulin Pumps Table 17. Major Manufacturers of Insulin Pens Table 18. Major Manufacturers of Insulin Syringes Table 19. Major Manufacturers of Others Table 20. Global Home Insulin Delivery (Dosing) Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2026) & (k units) Table 22. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2027-2032) & (k units) Table 23. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2026) Table 24. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2027-2032) Table 25. Global Home Insulin Delivery (Dosing) Devices Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2026) & (k units) Table 27. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2027-2032) & (k units) Table 28. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2026) Table 29. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Online Pharmacy Table 31. Major Manufacturers of Retail Pharmacy Table 32. Major Manufacturers of Hospitals Pharmacy Table 33. Global Home Insulin Delivery (Dosing) Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2026) & (k units) Table 35. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2027-2032) & (k units) Table 36. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2026) Table 37. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2027-2032) Table 38. Global Home Insulin Delivery (Dosing) Devices Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2026) & (k units) Table 40. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2027-2032) & (k units) Table 41. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2026) Table 42. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2027-2032) Table 43. Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026) & (k units) Table 45. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2021-2026) Table 46. Global Home Insulin Delivery (Dosing) Devices Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Home Insulin Delivery (Dosing) Devices Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 50. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 51. Europe Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 53. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 60. Global Home Insulin Delivery (Dosing) Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2021-2026) Table 64. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2027-2032) Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio Table 69. Medtronic Recent Development Table 70. Ypsomed Holding Company Information Table 71. Ypsomed Holding Business Overview Table 72. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio Table 74. Ypsomed Holding Recent Development Table 75. Wockhardt Company Information Table 76. Wockhardt Business Overview Table 77. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio Table 79. Wockhardt Recent Development Table 80. West Pharma Company Information Table 81. West Pharma Business Overview Table 82. West Pharma Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio Table 84. West Pharma Recent Development Table 85. Valeritas Company Information Table 86. Valeritas Business Overview Table 87. Valeritas Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio Table 89. Valeritas Recent Development Table 90. Tandem Diabetes Care Company Information Table 91. Tandem Diabetes Care Business Overview Table 92. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio Table 94. Tandem Diabetes Care Recent Development Table 95. SOOIL Company Information Table 96. SOOIL Business Overview Table 97. SOOIL Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio Table 99. SOOIL Recent Development Table 100. Sanofi Company Information Table 101. Sanofi Business Overview Table 102. Sanofi Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio Table 104. Sanofi Recent Development Table 105. Roche Holding AG Company Information Table 106. Roche Holding AG Business Overview Table 107. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio Table 109. Roche Holding AG Recent Development Table 110. Owen Mumford Company Information Table 111. Owen Mumford Business Overview Table 112. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio Table 114. Owen Mumford Recent Development Table 115. Novo Nordisk Company Information Table 116. Novo Nordisk Business Overview Table 117. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio Table 119. Novo Nordisk Recent Development Table 120. MannKind Company Information Table 121. MannKind Business Overview Table 122. MannKind Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio Table 124. MannKind Recent Development Table 125. Julphar Company Information Table 126. Julphar Business Overview Table 127. Julphar Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio Table 129. Julphar Recent Development Table 130. Insulet Corporation Company Information Table 131. Insulet Corporation Business Overview Table 132. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio Table 134. Insulet Corporation Recent Development Table 135. Eli Lilly and Company Company Information Table 136. Eli Lilly and Company Business Overview Table 137. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio Table 139. Eli Lilly and Company Recent Development Table 140. Debiotech Company Information Table 141. Debiotech Business Overview Table 142. Debiotech Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio Table 144. Debiotech Recent Development Table 145. Dance Biopharm Company Information Table 146. Dance Biopharm Business Overview Table 147. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio Table 149. Dance Biopharm Recent Development Table 150. Copernicus Company Information Table 151. Copernicus Business Overview Table 152. Copernicus Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio Table 154. Copernicus Recent Development Table 155. Biocon Company Information Table 156. Biocon Business Overview Table 157. Biocon Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio Table 159. Biocon Recent Development Table 160. Beta Bionics Company Information Table 161. Beta Bionics Business Overview Table 162. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio Table 164. Beta Bionics Recent Development Table 165. BD Company Information Table 166. BD Business Overview Table 167. BD Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. BD Home Insulin Delivery (Dosing) Devices Product Portfolio Table 169. BD Recent Development Table 170. B. Braun Company Information Table 171. B. Braun Business Overview Table 172. B. Braun Home Insulin Delivery (Dosing) Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio Table 174. B. Braun Recent Development Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Home Insulin Delivery (Dosing) Devices Distributors List Table 178. Home Insulin Delivery (Dosing) Devices Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Home Insulin Delivery (Dosing) Devices Product Image Figure 2. Global Home Insulin Delivery (Dosing) Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Insulin Delivery (Dosing) Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Home Insulin Delivery (Dosing) Devices Sales (2021-2032) & (k units) Figure 5. Global Home Insulin Delivery (Dosing) Devices Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Home Insulin Delivery (Dosing) Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Insulin Pumps Image Figure 9. Insulin Pens Image Figure 10. Insulin Syringes Image Figure 11. Others Image Figure 12. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Home Insulin Delivery (Dosing) Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2032) Figure 15. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2032) Figure 18. Online Pharmacy Image Figure 19. Retail Pharmacy Image Figure 20. Hospitals Pharmacy Image Figure 21. Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Home Insulin Delivery (Dosing) Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2032) Figure 24. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2032) Figure 27. North America Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032) Figure 29. U.S. Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032) Figure 34. Germany Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032) Figure 41. China Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2032) Figure 49. Brazil Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Home Insulin Delivery (Dosing) Devices Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Home Insulin Delivery (Dosing) Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Figure 60. North America Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Figure 62. Europe Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Home Insulin Delivery (Dosing) Devices Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Home Insulin Delivery (Dosing) Devices Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Others
Applications
  • Online Pharmacy
  • Retail Pharmacy
  • Hospitals Pharmacy
Companies covered
  • Medtronic
  • Ypsomed Holding
  • Wockhardt
  • West Pharma
  • Valeritas
  • Tandem Diabetes Care
  • SOOIL
  • Sanofi
  • Roche Holding AG
  • Owen Mumford
  • Novo Nordisk
  • MannKind
  • Julphar
  • Insulet Corporation
  • Eli Lilly and Company
  • Debiotech
  • Dance Biopharm
  • Copernicus
  • Biocon
  • Beta Bionics
  • BD
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Home Insulin Delivery (Dosing) Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Home Insulin Delivery (Dosing) Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Home Insulin Delivery (Dosing) Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Home Insulin Delivery (Dosing) Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Home Insulin Delivery (Dosing) Devices Market Dynamics
  1. 2.1 Home Insulin Delivery (Dosing) Devices Industry Trends
  2. 2.2 Home Insulin Delivery (Dosing) Devices Industry Drivers
  3. 2.3 Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges
  4. 2.4 Home Insulin Delivery (Dosing) Devices Industry Restraints
3 Home Insulin Delivery (Dosing) Devices Market by Manufacturers
  1. 3.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Home Insulin Delivery (Dosing) Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Home Insulin Delivery (Dosing) Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Home Insulin Delivery (Dosing) Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Home Insulin Delivery (Dosing) Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Home Insulin Delivery (Dosing) Devices Manufacturers, Product Type & Application
  7. 3.7 Global Home Insulin Delivery (Dosing) Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Home Insulin Delivery (Dosing) Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Home Insulin Delivery (Dosing) Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Home Insulin Delivery (Dosing) Devices Tier 1, Tier 2, and Tier 3
4 Home Insulin Delivery (Dosing) Devices Market by Type
  1. 4.1 Home Insulin Delivery (Dosing) Devices Type Introduction
  2. 4.1.1 Insulin Pumps
  3. 4.1.2 Insulin Pens
  4. 4.1.3 Insulin Syringes
  5. 4.1.4 Others
  6. 4.2 Global Home Insulin Delivery (Dosing) Devices Sales by Type
  7. 4.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Home Insulin Delivery (Dosing) Devices Sales by Type (2021-2032)
  9. 4.2.3 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2021-2032)
  10. 4.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Type
  11. 4.3.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2021-2032)
  13. 4.3.3 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2021-2032)
5 Home Insulin Delivery (Dosing) Devices Market by Application
  1. 5.1 Home Insulin Delivery (Dosing) Devices Application Introduction
  2. 5.1.1 Online Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospitals Pharmacy
  5. 5.2 Global Home Insulin Delivery (Dosing) Devices Sales by Application
  6. 5.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Home Insulin Delivery (Dosing) Devices Sales by Application (2021-2032)
  8. 5.2.3 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2021-2032)
  9. 5.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Application
  10. 5.3.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2021-2032)
  12. 5.3.3 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2021-2032)
6 Global Home Insulin Delivery (Dosing) Devices Sales by Region
  1. 6.1 Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Home Insulin Delivery (Dosing) Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Home Insulin Delivery (Dosing) Devices Revenue by Region
  1. 7.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Region
  2. 7.1.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Home Insulin Delivery (Dosing) Devices Revenue (2021-2032)
  8. 7.2.2 North America Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Home Insulin Delivery (Dosing) Devices Revenue (2021-2032)
  11. 7.3.2 Europe Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Home Insulin Delivery (Dosing) Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Ypsomed Holding
  8. 8.2.1 Ypsomed Holding Company Information
  9. 8.2.2 Ypsomed Holding Business Overview
  10. 8.2.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
  12. 8.2.5 Ypsomed Holding Recent Developments
  13. 8.3 Wockhardt
  14. 8.3.1 Wockhardt Company Information
  15. 8.3.2 Wockhardt Business Overview
  16. 8.3.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
  18. 8.3.5 Wockhardt Recent Developments
  19. 8.4 West Pharma
  20. 8.4.1 West Pharma Company Information
  21. 8.4.2 West Pharma Business Overview
  22. 8.4.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
  24. 8.4.5 West Pharma Recent Developments
  25. 8.5 Valeritas
  26. 8.5.1 Valeritas Company Information
  27. 8.5.2 Valeritas Business Overview
  28. 8.5.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
  30. 8.5.5 Valeritas Recent Developments
  31. 8.6 Tandem Diabetes Care
  32. 8.6.1 Tandem Diabetes Care Company Information
  33. 8.6.2 Tandem Diabetes Care Business Overview
  34. 8.6.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
  36. 8.6.5 Tandem Diabetes Care Recent Developments
  37. 8.7 SOOIL
  38. 8.7.1 SOOIL Company Information
  39. 8.7.2 SOOIL Business Overview
  40. 8.7.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
  42. 8.7.5 SOOIL Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Roche Holding AG
  50. 8.9.1 Roche Holding AG Company Information
  51. 8.9.2 Roche Holding AG Business Overview
  52. 8.9.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
  54. 8.9.5 Roche Holding AG Recent Developments
  55. 8.10 Owen Mumford
  56. 8.10.1 Owen Mumford Company Information
  57. 8.10.2 Owen Mumford Business Overview
  58. 8.10.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
  60. 8.10.5 Owen Mumford Recent Developments
  61. 8.11 Novo Nordisk
  62. 8.11.1 Novo Nordisk Company Information
  63. 8.11.2 Novo Nordisk Business Overview
  64. 8.11.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
  66. 8.11.5 Novo Nordisk Recent Developments
  67. 8.12 MannKind
  68. 8.12.1 MannKind Company Information
  69. 8.12.2 MannKind Business Overview
  70. 8.12.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
  72. 8.12.5 MannKind Recent Developments
  73. 8.13 Julphar
  74. 8.13.1 Julphar Company Information
  75. 8.13.2 Julphar Business Overview
  76. 8.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
  78. 8.13.5 Julphar Recent Developments
  79. 8.14 Insulet Corporation
  80. 8.14.1 Insulet Corporation Company Information
  81. 8.14.2 Insulet Corporation Business Overview
  82. 8.14.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
  84. 8.14.5 Insulet Corporation Recent Developments
  85. 8.15 Eli Lilly and Company
  86. 8.15.1 Eli Lilly and Company Company Information
  87. 8.15.2 Eli Lilly and Company Business Overview
  88. 8.15.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
  90. 8.15.5 Eli Lilly and Company Recent Developments
  91. 8.16 Debiotech
  92. 8.16.1 Debiotech Company Information
  93. 8.16.2 Debiotech Business Overview
  94. 8.16.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
  96. 8.16.5 Debiotech Recent Developments
  97. 8.17 Dance Biopharm
  98. 8.17.1 Dance Biopharm Company Information
  99. 8.17.2 Dance Biopharm Business Overview
  100. 8.17.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
  102. 8.17.5 Dance Biopharm Recent Developments
  103. 8.18 Copernicus
  104. 8.18.1 Copernicus Company Information
  105. 8.18.2 Copernicus Business Overview
  106. 8.18.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
  108. 8.18.5 Copernicus Recent Developments
  109. 8.19 Biocon
  110. 8.19.1 Biocon Company Information
  111. 8.19.2 Biocon Business Overview
  112. 8.19.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
  114. 8.19.5 Biocon Recent Developments
  115. 8.20 Beta Bionics
  116. 8.20.1 Beta Bionics Company Information
  117. 8.20.2 Beta Bionics Business Overview
  118. 8.20.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
  120. 8.20.5 Beta Bionics Recent Developments
  121. 8.21 BD
  122. 8.21.1 BD Company Information
  123. 8.21.2 BD Business Overview
  124. 8.21.3 BD Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 BD Home Insulin Delivery (Dosing) Devices Product Portfolio
  126. 8.21.5 BD Recent Developments
  127. 8.22 B. Braun
  128. 8.22.1 B. Braun Company Information
  129. 8.22.2 B. Braun Business Overview
  130. 8.22.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
  132. 8.22.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Home Insulin Delivery (Dosing) Devices Value Chain Analysis
  2. 9.1.1 Home Insulin Delivery (Dosing) Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Home Insulin Delivery (Dosing) Devices Production Mode & Process
  6. 9.2 Home Insulin Delivery (Dosing) Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Home Insulin Delivery (Dosing) Devices Distributors
  9. 9.2.3 Home Insulin Delivery (Dosing) Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst